[go: up one dir, main page]

AU2001245977A1 - Method and composition for preventing or reducing the symptoms of menopause - Google Patents

Method and composition for preventing or reducing the symptoms of menopause

Info

Publication number
AU2001245977A1
AU2001245977A1 AU2001245977A AU4597701A AU2001245977A1 AU 2001245977 A1 AU2001245977 A1 AU 2001245977A1 AU 2001245977 A AU2001245977 A AU 2001245977A AU 4597701 A AU4597701 A AU 4597701A AU 2001245977 A1 AU2001245977 A1 AU 2001245977A1
Authority
AU
Australia
Prior art keywords
menopause
symptoms
preventing
reducing
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001245977A
Inventor
Debasis Bagchi
Gary Troxel
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Lonza Consumer Health Inc
Original Assignee
Interhealth Nutraceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Interhealth Nutraceuticals Inc filed Critical Interhealth Nutraceuticals Inc
Publication of AU2001245977A1 publication Critical patent/AU2001245977A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/67—Piperaceae (Pepper family), e.g. Jamaican pepper or kava
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/84—Valerianaceae (Valerian family), e.g. valerian
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Botany (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Endocrinology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Reproductive Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU2001245977A 2000-03-23 2001-03-23 Method and composition for preventing or reducing the symptoms of menopause Abandoned AU2001245977A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US19163400P 2000-03-23 2000-03-23
US60191634 2000-03-23
PCT/US2001/009489 WO2001070212A2 (en) 2000-03-23 2001-03-23 Method and composition for preventing or reducing the symptoms of menopause

Publications (1)

Publication Number Publication Date
AU2001245977A1 true AU2001245977A1 (en) 2001-10-03

Family

ID=22706273

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001245977A Abandoned AU2001245977A1 (en) 2000-03-23 2001-03-23 Method and composition for preventing or reducing the symptoms of menopause

Country Status (3)

Country Link
US (1) US20010039296A1 (en)
AU (1) AU2001245977A1 (en)
WO (1) WO2001070212A2 (en)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030190381A1 (en) * 2001-02-02 2003-10-09 Bland Jeffrey S. Medical composition for balancing bodily processes
US20040220118A1 (en) * 2001-02-02 2004-11-04 Bland Jeffrey S. Medical composition for balancing bodily processes
US20070059378A1 (en) * 2001-02-02 2007-03-15 Metagenics, Inc. Medical composition for balancing bodily processes
US20060034954A1 (en) * 2001-02-02 2006-02-16 Bland Jeffrey S Medical composition for balancing bodily processes
US7977049B2 (en) 2002-08-09 2011-07-12 President And Fellows Of Harvard College Methods and compositions for extending the life span and increasing the stress resistance of cells and organisms
AU2004253579B2 (en) 2003-07-01 2010-12-23 Biomol International L.P. Sirt1 modulators for manipulating cells/organism lifespan/stress response
US7758902B2 (en) * 2003-09-12 2010-07-20 Access Business Group International Llc Cytokine modulators and related methods of use
WO2005025586A1 (en) * 2003-09-12 2005-03-24 Access Business Group International Llc Cytokine modulators and related method of use
US7758903B2 (en) 2003-09-12 2010-07-20 Access Business Group International Llc Cytokine modulators and related methods of use
US20090169585A1 (en) * 2003-10-23 2009-07-02 Resveratrol Partners, Llc Resveratrol-Containing Compositions And Their Use In Modulating Gene Product Concentration Or Activity
US20050158376A1 (en) * 2003-10-23 2005-07-21 Sardi William F. Dietary supplement and method of processing same
US8017634B2 (en) 2003-12-29 2011-09-13 President And Fellows Of Harvard College Compositions for treating obesity and insulin resistance disorders
US20050171027A1 (en) * 2003-12-29 2005-08-04 President And Fellows Of Harvard College Compositions for treating or preventing obesity and insulin resistance disorders
WO2006079021A2 (en) * 2005-01-20 2006-07-27 Sirtris Pharmaceuticals, Inc. Use of sirtuin-activating compounds for treating flushing and drug induced weight gain
EP1845962A1 (en) * 2005-02-04 2007-10-24 Peter Heger Use of active ingredients containing hydroxystilbene for preventing and/or treating osteoporosis
WO2006138418A2 (en) 2005-06-14 2006-12-28 President And Fellows Of Harvard College Improvement of cognitive performance with sirtuin activators
US8338393B2 (en) * 2008-03-24 2012-12-25 Primus Pharmaceuticals, Inc. Combination dosage forms and therapies for supporting bone health
DE102008035285A1 (en) * 2008-07-02 2010-01-07 Hermann-Josef Wilhelm Extraction of active substances from group of anthraquinone and phenols and/or polyphenols from a plant, where new plant variety Igniscum (CPVO 2007/0149) or Candy (CPVO 2007/1958) registered to variety protection is requisitioned as plant
DE102008037337A1 (en) * 2008-08-11 2010-02-25 Hermann-Josef Wilhelm Process for the preparation of active substances, in particular phenols from a plant
IT1404171B1 (en) * 2011-02-10 2013-11-15 Paladin Pharma S P A COMPOSITION FOR USE IN THE TREATMENT OF PROBLEMS / DISORDERS OF THE MENOPAUSE AND IN THE TREATMENT OF THE GENERAL AGING OF THE ORGANISM
US8916528B2 (en) 2011-11-16 2014-12-23 Resveratrol Partners, Llc Compositions containing resveratrol and nucleotides
IT201600075405A1 (en) * 2016-07-19 2018-01-19 Frima Res Srls COMPOSITIONS FOR THE TREATMENT OF THE MENOPAUSE SYMPTOMS
AU2017100368A4 (en) * 2016-09-23 2017-05-18 The University Of Newcastle Methods for improving cerebrovascular function and cognition in peri- and post-menopausal women
NL1044090B1 (en) * 2020-08-12 2022-07-15 Dr Jelena Barjaktarovic Md Combination of vitamin B6, ginseng, green tea extract, Ganoderma lucidum, black cohosh root, nicotinamide mononucleotide (NMN) and resveratrol as a healthy functional food (food supplement)

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5516528A (en) * 1995-01-13 1996-05-14 Wake Forest University Dietary phytoestrogen in estrogen replacement therapy
US5707630A (en) * 1996-01-04 1998-01-13 Sabina International, Ltd. Herbal compound for relief of PMS through menopausal symptoms
WO1999065337A1 (en) * 1998-06-19 1999-12-23 Beth Israel Deaconess Medical Center Dietary supplement for post-menopausal women
IT1299191B1 (en) * 1998-06-23 2000-02-29 Sigma Tau Healthscience Spa COMPOSITION TO PREVENT AND TREAT OSTEOPOROSIS AND ALTERATIONS RELATED TO MENOPAUSE
EP1072265A1 (en) * 1999-07-20 2001-01-31 MEDIS S.r.l. Medical Infusion Systems Use of plant polyphenols for treating iron overload
US6358517B1 (en) * 1999-10-22 2002-03-19 Unilever Home & Personal Care Usa, Division Of Conopco Cosmetic compositions containing resveratrol and retinoids

Also Published As

Publication number Publication date
US20010039296A1 (en) 2001-11-08
WO2001070212A3 (en) 2002-05-23
WO2001070212A2 (en) 2001-09-27

Similar Documents

Publication Publication Date Title
AU2001245977A1 (en) Method and composition for preventing or reducing the symptoms of menopause
AU2001245437A1 (en) Lightweight methods and compositions for well treating
AU2001261566A1 (en) Well service composition and method
AU5294100A (en) Method and compositions for treating the inflammatory response
AU2001280604A1 (en) Compositions comprising icariside i and anhydroicaritin and methods for making the same
AU5006499A (en) Compositions and methods for the treatment or prevention of pulmonary infections
AU2001233932A1 (en) Method and composition
AU2002239258A1 (en) Houttuyninum compositions and methods for inhibiting the activity of erbb-2 based thereon
AU2001264522A1 (en) Methods and compositions for the prevention of myopia
AU2002245510A1 (en) Method and composition for embalming
AU2001255580A1 (en) Methods and compositions for the diagnosis of schizophrenia
AU2002303552A1 (en) Methods and compositions for prevention of angioproliferation
AU2001261513A1 (en) Composition and method for increasing testosterone levels
AU2002239775A1 (en) Chemical-library composition and method
AU2002228500A1 (en) Methods and compositions for reducing or preventing onset of milk fever
AU2002217915A1 (en) Compositions and methods for diagnosing or treating psoriasis
AU2000265105A1 (en) Methods and compositions for the prevention and treatment of syndrome x
AU2149600A (en) Methods and compositions for treating common cold symptoms
AU5931300A (en) Ringene compositions and methods for use thereof
AU2001249194A1 (en) Immunokine composition and method
AU2001257164A1 (en) Methods and compositions for the diagnosis of schizophrenia
AU3964100A (en) Corrosive preventive composition and method of using the same
AU2001259127A1 (en) Methods and composition for the diagnosis of schizophrenia
AU7621800A (en) Methods and compositions for reducing sympathomimetic-induced side effects
AU2001231129A1 (en) Methods and compositions for bioremediation